Swen JJ - Search Results

1

Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis.

Knikman JE, Wilting TA, Lopez-Yurda M, Henricks LM, Lunenburg CATC, de Man FM, Meulendijks D, Nieboer P, Droogendijk HJ, Creemers GJ, Mandigers CMPW, Imholz ALT, Mathijssen RHJ, Portielje JEA, Valkenburg-van Iersel L, Vulink A, van der Poel MHW, Baars A, Swen JJ, Gelderblom H, Schellens JHM, Beijnen JH, Guchelaar HJ, Cats A. Knikman JE, et al. Among authors: swen jj. J Clin Oncol. 2023 Dec 10;41(35):5411-5421. doi: 10.1200/JCO.22.02780. Epub 2023 Aug 28. J Clin Oncol. 2023. PMID: 37639651

2

Translating pharmacogenomics: challenges on the road to the clinic.

Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, Guchelaar HJ. Swen JJ, et al. PLoS Med. 2007 Aug;4(8):e209. doi: 10.1371/journal.pmed.0040209. PLoS Med. 2007. PMID: 17696640 Free PMC article. Review.

3

Use of plasmid-derived external quality control samples in pharmacogenetic testing.

van der Straaten T, Swen J, Baak-Pablo R, Guchelaar HJ. van der Straaten T, et al. Pharmacogenomics. 2008 Sep;9(9):1261-6. doi: 10.2217/14622416.9.9.1261. Pharmacogenomics. 2008. PMID: 18781854 Review.

4

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus.

Swen JJ, Wessels JA, Krabben A, Assendelft WJ, Guchelaar HJ. Swen JJ, et al. Pharmacogenomics. 2010 Nov;11(11):1517-23. doi: 10.2217/pgs.10.121. Pharmacogenomics. 2010. PMID: 21121772

5

Genetic risk factors for type 2 diabetes mellitus and response to sulfonylurea treatment.

Swen JJ, Guchelaar HJ, Baak-Pablo RF, Assendelft WJ, Wessels JA. Swen JJ, et al. Pharmacogenet Genomics. 2011 Aug;21(8):461-8. doi: 10.1097/FPC.0b013e3283478173. Pharmacogenet Genomics. 2011. PMID: 21633322

6

Comment: global formulary review: how do we integrate pharmacogenomic information?

Swen JJ, Guchelaar HJ. Swen JJ, et al. Ann Pharmacother. 2011 Jul;45(7-8):1030; author reply 1030-1. doi: 10.1345/aph.1P557a. Epub 2011 Jul 20. Ann Pharmacother. 2011. PMID: 21775697 No abstract available.

7

SNPs and haplotypes in DPYD and outcome of capecitabine--Letter.

Opdam FL, Swen JJ, Wessels JA, Gelderblom H. Opdam FL, et al. Among authors: swen jj. Clin Cancer Res. 2011 Sep 1;17(17):5833-4; author reply 5835-6. doi: 10.1158/1078-0432.CCR-11-1208. Epub 2011 Aug 30. Clin Cancer Res. 2011. PMID: 21878541 No abstract available.

8

Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene.

Swen JJ, Baak-Pablo RF, Guchelaar HJ, van der Straaten T. Swen JJ, et al. Clin Chem Lab Med. 2011 Oct 21;50(2):279-84. doi: 10.1515/CCLM.2011.758. Clin Chem Lab Med. 2011. PMID: 22022982

9

The challenges of developing a 'medical-grade' genome.

van der Straaten T, Guchelaar HJ, Swen JJ. van der Straaten T, et al. Among authors: swen jj. Pharmacogenomics. 2012 Mar;13(4):369-72. doi: 10.2217/pgs.12.6. Pharmacogenomics. 2012. PMID: 22379992 No abstract available.

10

Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.

Dávila-Fajardo CL, Swen JJ, Cabeza Barrera J, Guchelaar HJ. Dávila-Fajardo CL, et al. Among authors: swen jj. Pharmacogenomics. 2013 Jan;14(1):63-73. doi: 10.2217/pgs.12.183. Pharmacogenomics. 2013. PMID: 23252949 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters